COLL - Collegium Pharmaceutical Inc. (COLL) CEO Joe Ciaffoni on Q3 2021 Results - Earnings Call Transcript

Collegium Pharmaceutical, Inc. (COLL) Q3 2021 Earnings Conference Call November 4, 2021, 04:30 PM ET Company Participants Julie Fallon - Senior Vice President, Investor Relations, MacDougall Advisors Joe Ciaffoni - President, CEO & Director Colleen Tupper - EVP & CFO Scott Dreyer - EVP & Chief Commercial Officer Conference Call Participants David Amsellem - Piper Sandler & Co. David Steinberg - Jefferies Serge Belanger - Needham & Company Oren Livnat - H.C. Wainwright Greg Fraser - Truist Securities Presentation Operator Greetings, and welcome to Collegium Pharmaceutical Third Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Julie Fallon. Thank you. You may begin. Julie Fallon Welcome to Collegium Pharmaceuticals third quarter 2021 earnings

For further details see:

Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q3 2021 Results - Earnings Call Transcript